Editorial: Pharmaceutical biomaterials
Donghan Shao, Donghan Shao, Yuqin Ma and 9 more
Frontiers in Bioengineering and Biotechnology · 2025
doi:10.3389/fbioe.2025.1661817 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Biomaterial-pharmaceutical convergence advances smart drug delivery.Engineered biomaterials enable precise therapies via biocompatibility/tunability. This collection showcases multifunctional systems through 32 contributions, spanning composites to translational research for clinical translation.Functional biomaterials integrated into multi-scale bionic designs Collectively, these advances mark a transformative shift toward realtime interactive therapeutic platforms. By converging materials science, biology, and engineering, the field delivers clinically viable solutions that dynamically intercept disease progression, enabling adaptive precision medicine.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.